兰克尔
破骨细胞
抗酒石酸酸性磷酸酶
骨吸收
骨重建
功能(生物学)
函数增益
生物
医学
突变
内科学
细胞生物学
内分泌学
遗传学
基因
受体
激活剂(遗传学)
作者
Xin Ren,Wenhua Shan,Lulu Wei,Chan‐Chan Gong,Dong-Sheng Pei
出处
期刊:Anti-cancer Agents in Medicinal Chemistry
[Bentham Science]
日期:2018-12-28
卷期号:18 (8): 1082-1090
被引量:18
标识
DOI:10.2174/1871520618666180411123447
摘要
Background: Tartrate-resistant acid phosphatase 5 (ACP5) is an evolutionarily conserved and multifunctional protein that is involved in generations of reactive oxygen species, normal bone development, osteoblast regulation and macrophage function, affecting a series of pathways, as well as reflecting bone resorption and osteoclast activity. Methods: Literature searches, systematic reviews and assessments about the structure, distribution, regulation and novel functions of ACP5 were performed in this review from PubMed and Medline databases. Results: Studies demonstrate that RANKL can increase the expression of ACP5 through NFATc1 and c-Fos to accelerate osteoclastogenesis, which also can be regulated by many regulators. Based on the aforementioned information, it is shown that ACP5, together with the phosphatase activity, can medicate the progression and development of human genetic diseases and cancer. Conclusion: As a novel target, ACP5 plays a critical role in preventing, monitoring and treating various kinds of tumors, as well as accelerating the development of a promising therapeutic strategy for human genetic diseases. However, the explicit mechanism between ACP5 and cancer is not so clear. It is necessary and significant for us to pay more in-depth attention.
科研通智能强力驱动
Strongly Powered by AbleSci AI